The Complex Connection Between Cannabis And Schizophrenia by Michael T. ComptonThe Complex Connection Between Cannabis And Schizophrenia by Michael T. Compton

The Complex Connection Between Cannabis And Schizophrenia

byMichael T. Compton

Paperback | August 26, 2017

Pricing and Purchase Info

$76.37 online 
$110.50 list price save 30%
Earn 382 plum® points

Prices and offers may vary in store


Ships within 1-2 weeks

Ships free on orders over $25

Not available in stores


The Complex Connection between Cannabis and Schizophreniaprovides an in-depth overview of the current state of research into the role that cannabis plays in schizophrenia, covering both the pathophysiological and the pharmacological implications. It addresses the epidemiology of cannabis use and the risks associated with its use, the biological aspects of the drug, its effects on the brain and the pharmacological possibilities of using cannabidiol to treat schizophrenia.

It is the only book on the market devoted exclusively to examining the links between this very commonly used (and misused) drug and a specific set of devastating psychiatric illnesses, providing a comprehensive guide to our current understandings of this relationship.

Marijuana is the most commonly used illicit drug globally, and is becoming increasingly decriminalized and even legalized worldwide. Among the numerous mental-health concerns related to the drug, there is mounting evidence of an intricate link between cannabis use and schizophrenia and related psychotic disorders. At the same time, there is promising evidence to suggest that cannabidiol, one of the many compounds found in cannabis that activates the brain's cannabinoid receptors, could prove to be an effective antipsychotic to treat schizophrenia.

  • Synthesizes existing knowledge about the confusing, but crucial, relationship between cannabis use and schizophrenia symptoms
  • Provides a comprehensive overview of the neurobiological mechanisms of cannabis use and its effects on the brain, including an exploration of the endocannabinoid system
  • Examines the promising evidence suggesting cannabidiol as an effective antipsychotic treatment for schizophrenia
  • Aids readers studying the neurobiological underpinning of cannabis addiction and psychosis in determining directions for their own future research
Professor of Clinical Psychiatry, Columbia University College of Physicians and Surgeons, NY, USAClinical Assistant Professor of Psychiatry, New York University School of Medicine, NY USA
Title:The Complex Connection Between Cannabis And SchizophreniaFormat:PaperbackDimensions:362 pages, 8.75 × 6.35 × 0.68 inPublished:August 26, 2017Publisher:Academic PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0128047917

ISBN - 13:9780128047910

Look for similar items by category:


Table of Contents

1. Introduction to the Complex Connection between Cannabis Use and Psychosis, Psychotic Disorders, and Schizophrenia00

Marc W. Manseau and Michael T. Compton

2. The Epidemiology of Cannabis Use in the United States

00Wilson M. Compton and Beth Han

3. The Biology of Cannabis in the Brain, and the Endocannabinoid System

00David Louis Atkinson and Jeff. K. Abbott

4. Psychotomimetic and Cognitive Effects of 9-Tetrahydrocannabinol in Laboratory Settings

John D. Cahill, Swapnil Gupta, Jose Cortes-Briones, Rajiv Radhakrishnan, Mohamed Sherif, Deepak C. D'Souza

5. Psychotomimetic and Cognitive Effects of Cannabis Use in the General Population

00Nadia Solowij

6. Effects of Cannabis Use among those with Schizotypy

00Angelo B. Cedeno

7. Effects of Cannabis Use among those at Clinical High Risk for Schizophrenia

00Brian O'Donoghue, Meredith McHugh, Barnaby Nelson, and Patrick McGorry

8. Cannabis-Induced Psychotic Disorders

00Luca Pauselli

9. Synthetic Cannabinoids and Synthetic Cannabinoid-Induced Psychotic Disorders

00Papanti Duccio, Schifano Fabrizio, and Orsolini Laura

10. Cannabis Use as an Independent Risk Factor for, or Component Cause of, Schizophrenia and Related Psychotic Disorders

00Jodi M. Gilman, Sara M. Sobolewski, and Anne Eden Evins

11. Cannabis Use as a Determinant of Earlier Age at Onset of Schizophrenia and Related Psychotic Disorders

00Claire Ransay Wan and Beth Broussard

12. The Prevalence of Cannabis Use, and Effects on Course and Outcomes, among Individuals with Schizophrenia and Related Psychotic Disorders00

Ana Fresán, Rebeca Robles-García, and Carlos-Alfonso Tovilla-Zarate

13. The Treatment of Cannabis Use Disorders among Individuals with Psychotic Disorders

00Peter Bosanac, Ana Lusicic, and David J. Castle

14. Cannabidiol as a Potential Novel Therapeutic Agent for Psychotic Disorders

00Serena Deiana and Erica Zamberletti